TEAD2 and multiple acyl-CoA dehydrogenase deficiency: For example, while the median age of first symptoms in late-onset MADD associated with ETF-QO variants has been reported to be 19.2 years, in some cases, individuals experience the onset of symptoms in their sixth and seventh decades [86].